The Department of Veterans Affairs Approves
Purchase of FMCNA Products in Five Categories
WALTHAM,
Mass., Aug. 30, 2022 /PRNewswire/
-- Fresenius Medical North America's (FMCNA) Renal Therapies
Group, the leading provider of kidney care products, will be a
company of choice to help treat the more than 35,000 military
veterans receiving dialysis from the U.S. Department of Veterans
Affairs (VA). The VA awarded a five-year contract to FMCNA in five
different categories, the most of any medical device company,
including home dialysis machines, critical care equipment, water
purification systems, and in-center hemodialysis.
"We are extremely proud to continue our decades-long
relationship with Veterans Affairs and serving the men and women
who have given so much for their country," said Joe Turk, President of the Renal Therapies Group
at Fresenius Medical Care North America. "This contract is a
testament to our innovation, industry-leading technology, and our
ability to meet the needs of our veterans, whether they require
dialysis in the hospital, in an outpatient setting, and more
increasingly at home."
Under the five-year national contract, the VA's 106 hospitals
and clinics can purchase Fresenius Medical Care's complete
in-center, acute, and home dialysis offerings. This commitment by
the VA allows our veterans access to a continuity of care by the
industry's leading provider.
The VA endorsement includes the industry leading 2008T BlueStar
hemodialysis machine which provides life-sustaining dialysis care
with the addition of the industry's only integrated fluid
management technology. The contract also includes the
NxStage® System One S™ with NxView for hospital systems to provide
Continuous Renal Replacement Therapy (CRRT) to patients with acute
kidney injury, as well as the The AquaC UNO H, a portable water
treatment system featuring a compact footprint.
Two home dialysis systems from Fresenius Medical Care also
received this VA endorsement, including the company's NxStage
Versi™HD and Liberty® Select Cycler.
Empowering more patients to choose home dialysis is a key priority
for the company and the government as it can provide veterans
greater lifestyle flexibility and independence.
"Fresenius Medical Care has been a leader in dialysis services
for many decades," said Dr. Mink Chawla, the former chief of
critical care at the Washington,
D.C., VA Medical Center. "Our veterans deserve the best
care, and I am delighted they will have access to Fresenius Medical
Care's state-of-the-art devices and services."
The contract is effective from August 1,
2022, through July 31,
2027.
About Fresenius Medical Care North
America
Fresenius Medical Care North America (FMCNA) is the premier
healthcare company focused on providing the highest quality care to
people with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities and outpatient
cardiac and vascular labs, Fresenius Medical Care North America
provides coordinated healthcare services at pivotal care points for
hundreds of thousands of chronically ill customers throughout the
continent. As the world's largest fully integrated renal company,
it offers specialty pharmacy and laboratory services, and
manufactures and distributes the most comprehensive line of
dialysis equipment, disposable products, and renal pharmaceuticals.
For more information, visit the Fresenius Medical Care North
America website at https://fmcna.com/.
Media Contact:
Fresenius Medical Care
Scott
Sayres
Corporate Communications
Scott.Sayres@FreseniusMedicalCare.com
+1 (940) 297-5678
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-wins-major-award-to-support-us-veterans-with-industry-leading-dialysis-care-301614824.html
SOURCE Fresenius Medical Care Holdings, Inc.